These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Does diabetes begin with insulin resistance? Kipnis D Adv Metab Disord; 1970; 1():Suppl 1:171+. PubMed ID: 5446891 [No Abstract] [Full Text] [Related]
4. The insulin response to glucagon: effects of diabetes and obesity on nonglucose-dependent insulin secretion. Hazzard WR; Crockford PM; Williams RH Diabetes; 1968; 17():297. PubMed ID: 5651714 [No Abstract] [Full Text] [Related]
5. [Effect of insulin treatment on insulin secretion and insulin resistance in obese type II diabetics]. Hidaka H Horumon To Rinsho; 1982 Jul; 30(7):699-704. PubMed ID: 6751623 [No Abstract] [Full Text] [Related]
6. [Actual problems of diabetes mellitus]. Balabolkin MI Sov Med; 1989; (11):3-7. PubMed ID: 2697087 [No Abstract] [Full Text] [Related]
7. [Respective roles of insulin resistance and disorders of secretion of this hormone in the non-insulin-dependent diabetic]. Vague P Journ Annu Diabetol Hotel Dieu; 1982; ():7-17. PubMed ID: 7047844 [No Abstract] [Full Text] [Related]
8. [HLA antigens, hormonal profile and insulin antibodies in insulin-dependent diabetes mellitus with retinopathy]. Vasiukova EA; Guliaeva ES; Kantsel'son LA; Kniazev IuA; Mikhaĭlova NA Klin Med (Mosk); 1981 Nov; 59(11):42-6. PubMed ID: 7033655 [No Abstract] [Full Text] [Related]
9. [Pathogenesis and the basic principles of treating diabetes mellitus]. Baranov VG Vestn Akad Med Nauk SSSR; 1980; (7):10-8. PubMed ID: 6998174 [No Abstract] [Full Text] [Related]
10. Insulin secretion, insulin resistance, and obesity. DeFronzo RA Int J Obes; 1982; 6 Suppl 1():73-82. PubMed ID: 6749725 [No Abstract] [Full Text] [Related]
11. [Current trends in the treatment of diabetes mellitus]. Jacobelli A Clin Ter; 1984 Aug; 110(3):277-81. PubMed ID: 6237866 [No Abstract] [Full Text] [Related]
12. [Behavior of blood levels of I.R.I. in obese persons after endovenous tolubtamide loading]. Artenisio AC; Allegra V; Albanese MC; Sprovieri M; Alibrando S; Caruso A; Corsi V Folia Endocrinol; 1972 Aug; 25(4):286-99. PubMed ID: 4678218 [No Abstract] [Full Text] [Related]
13. [Pathogenetic relationship between insulin resistance, insulin secretion and impaired glucose tolerance in patients with obesity]. Abdurakhmanova AM; Kosovskiĭ MI; Rakhimov NR; Guliamov TD Probl Endokrinol (Mosk); 1988; 34(2):21-4. PubMed ID: 3293029 [TBL] [Abstract][Full Text] [Related]
14. Role of insulin receptors in insulin-resistant states. Kahn CR Metabolism; 1980 May; 29(5):455-66. PubMed ID: 6990180 [TBL] [Abstract][Full Text] [Related]
15. Obesity and insulin resistance in Swedish subjects. Arner P Diabet Med; 1996 Sep; 13(9 Suppl 6):S85-6. PubMed ID: 8894488 [TBL] [Abstract][Full Text] [Related]
16. [Role of insulin resistance in the pathogenesis of diabetes mellitus]. Reaven GM Medicina (B Aires); 1978; 38(5):577-86. PubMed ID: 368502 [No Abstract] [Full Text] [Related]
17. [Insulin in the serum and antibody levels]. Fernández-Cruz A; López-Quijada C Rev Iber Endocrinol; 1972; 19(112):371-85. PubMed ID: 5054128 [No Abstract] [Full Text] [Related]
18. Insulin resistance is not necessarily an essential component of type 2 diabetes. Gerich JE J Clin Endocrinol Metab; 2000 Jun; 85(6):2113-5. PubMed ID: 10852436 [No Abstract] [Full Text] [Related]
19. [Behavior of the serum I.R.I. in persons with latent diabetes after endovenous tolbutamide load]. Artenisio AC; Albanese MC; Allegra V; Alibrando S; Caruso A; Sprovieri M; Corsi V Folia Endocrinol; 1972 Aug; 25(4):300-11. PubMed ID: 4678219 [No Abstract] [Full Text] [Related]
20. [Insulin resistance in diabetes in the obese subject]. Denard Y; Darnaud J; Barousse C; Navez I Journ Annu Diabetol Hotel Dieu; 1984; ():137-49. PubMed ID: 6399530 [No Abstract] [Full Text] [Related] [Next] [New Search]